CareReview Appoints Adam Schilling as Chief Growth Officer to Drive Healthcare Expansion

CareReview Expands Leadership with New Chief Growth Officer

CareReview, a leading provider of independent clinical review solutions in the healthcare sector, has announced a significant appointment as part of its strategy to enhance its market presence. Adam Schilling has joined the company as the Chief Growth Officer, a role that positions him at the helm of the company's expansion efforts across various healthcare segments.

The need for effective healthcare solutions has never been more pressing, especially in light of recent developments in the healthcare industry. CareReview has carved out a strong reputation for itself by delivering evidence-based clinical reviews for workers' compensation and disability across all 50 states. Now, with Schilling on board, the company plans to leverage its extensive expertise in group health, commercial and government health plans, pharmacy benefit managers (PBMs), third-party administrators (TPAs), and self-funded organizations.

Leadership Experience

Schilling brings over 20 years of experience in healthcare commercial leadership roles. His journey includes valuable positions at well-respected organizations such as ExamWorks, Medical Review Institute of America (MRIoA), and Advanced Medical Reviews (AMR). His breadth of knowledge and established relationships within the industry are seen as pivotal assets for driving the company's growth strategy.

Ross Crutchfield, Founder and CEO of CareReview, acknowledged that Schilling's appointment comes at a critical juncture in the company's evolution. "Adam brings exactly the combination of industry knowledge, relationships, and growth leadership critical to CareReview's next chapter," Crutchfield stated. He emphasized the necessity of partnership and support for healthcare organizations, a quality Schilling embodies.

Strategic Market Expansion

As Chief Growth Officer, Schilling will lead the charge in CareReview's ambitions to expand its clinical solutions. The company’s Clinical Solutions Optimizing Care™ model aims to provide an array of services which include utilization management, independent review and appeals, nurse review, payment integrity, and peer review.

"CareReview is founder-led, with an experienced team and disciplined operations behind the work," remarked Schilling in his statement. He elaborated on his career devoted to understanding the needs of healthcare organizations and reasserted his commitment to maintaining the quality of clinical determinations, even during periods of rapid growth.

Comprehensive Clinical Review Solutions

CareReview's depth of services spans both group health and pharmacy solutions, with an emphasis on patient care quality. By utilizing a nationwide network of licensed clinical specialists and cutting-edge technology through their proprietary platform, Stradix®, CareReview aims to enhance service delivery and operational efficiency.

Currently, CareReview holds URAC Independent Review Organization accreditation along with HITRUST r2 Certification, with ongoing efforts for re-accreditation and NCQA accreditation. These credentials underscore the company's commitment to adhering to the highest standards of healthcare review processes and performance metrics.

A Growing Commitment to Partnerships

Founded in 2011, CareReview has been steadfast in providing independent clinical review solutions that foster long-term collaborations. The company’s approach is rooted in clinical integrity, responsive service, and measurable outcomes—these tenets guide their work not just for today but for the future as well.

With Schilling’s leadership, CareReview is well-positioned to capitalize on the rising demands within the healthcare sector, fortifying its role as a vital partner to healthcare organizations.

For more information about CareReview and its innovative clinical solutions, visit CareReview.com.